Company Data
Unicycive Therapeutics Inc.
Ticker
UNCY
Current Price
$0.49 -2.47%
Market Cap
$17.0M
Price Target
Refer to Report
Volume
104.4K
52wk Range
$0.4004 - $2.87
Overview
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company’s lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive’s other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.